Arvicola amphibius chromosome 15, mArvAmp1.2, whole genome shotgun sequence.
Arvicola amphibius (Eurasian water vole)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Cricetidae; Arvicolinae; Arvicola.
REFSEQ INFORMATION: The reference sequence is identical to\nLR862395.1.\nAssembly name: mArvAmp1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Wellcome Sanger Institute on\n2021/05/15. The original whole-genome shotgun project has the\naccession CAJEUG000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Arvicola amphibius Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins
protein transport protein Sec61 subunit gamma-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
aspartate aminotransferase, mitochondrial
solute carrier family 38 member 7, transcript variant X1
solute carrier family 38 member 7, transcript variant X3
solute carrier family 38 member 7, transcript variant X2
putative sodium-coupled neutral amino acid transporter 7 isoform X2
putative sodium-coupled neutral amino acid transporter 7 isoform X1
CCR4-NOT transcription complex subunit 1, transcript variant X4
CCR4-NOT transcription complex subunit 1, transcript variant X1
CCR4-NOT transcription complex subunit 1, transcript variant X3
CCR4-NOT transcription complex subunit 1, transcript variant X2
CCR4-NOT transcription complex subunit 1, transcript variant X6
CCR4-NOT transcription complex subunit 1, transcript variant X8
CCR4-NOT transcription complex subunit 1, transcript variant X5
CCR4-NOT transcription complex subunit 1, transcript variant X7
CCR4-NOT transcription complex subunit 1 isoform X1
CCR4-NOT transcription complex subunit 1 isoform X5
CCR4-NOT transcription complex subunit 1 isoform X3
CCR4-NOT transcription complex subunit 1 isoform X7
CCR4-NOT transcription complex subunit 1 isoform X2
CCR4-NOT transcription complex subunit 1 isoform X6
CCR4-NOT transcription complex subunit 1 isoform X4
CCR4-NOT transcription complex subunit 1 isoform X8
COORDINATES: nucleotide motif:Rfam:12.0:RF00407
COORDINATES: nucleotide motif:Rfam:12.0:RF00404
SET domain containing 6, protein lysine methyltransferase
NDRG family member 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X8
NDRG family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X4
NDRG family member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
NDRG family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA replication complex GINS protein PSF3
serine protease 54, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
serine protease 54, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
coiled-coil domain containing 113, transcript variant X3
coiled-coil domain containing 113, transcript variant X1
coiled-coil domain-containing protein 113 isoform X3
coiled-coil domain-containing protein 113 isoform X1
coiled-coil domain containing 113, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain-containing protein 113 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
cilia and flagella associated protein 20
cilia- and flagella-associated protein 20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 319, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 319, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
testis, prostate and placenta expressed, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
testis, prostate and placenta expressed, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
testis, prostate and placenta-expressed protein isoform X2
testis, prostate and placenta-expressed protein isoform X1
cyclic nucleotide gated channel subunit beta 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
cyclic nucleotide-gated cation channel beta-1
kinesin family member C3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member C3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member C3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member C3, transcript variant X4
kinesin family member C3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
katanin regulatory subunit B1, transcript variant X2
katanin regulatory subunit B1, transcript variant X1
katanin regulatory subunit B1, transcript variant X3
katanin p80 WD40 repeat-containing subunit B1 isoform X2
katanin p80 WD40 repeat-containing subunit B1 isoform X1
katanin p80 WD40 repeat-containing subunit B1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor G1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adhesion G protein-coupled receptor G1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
adhesion G protein-coupled receptor G1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adhesion G protein-coupled receptor G1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adhesion G protein-coupled receptor G5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor G5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G-protein coupled receptor G5 isoform X2
adhesion G-protein coupled receptor G5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain-containing protein 102A
DNA-directed RNA polymerase II subunit RPB3
ubiquinone biosynthesis protein COQ9, mitochondrial isoform X1
ubiquinone biosynthesis protein COQ9, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
C-X3-C motif chemokine ligand 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-X3-C motif chemokine ligand 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ADP ribosylation factor like GTPase 2 binding protein, transcript variant X1
ADP ribosylation factor like GTPase 2 binding protein, transcript variant X2
ADP-ribosylation factor-like protein 2-binding protein isoform X1
ADP-ribosylation factor-like protein 2-binding protein isoform X2
ring finger and SPRY domain containing 1, transcript variant X1
ring finger and SPRY domain containing 1, transcript variant X2
RING finger and SPRY domain-containing protein 1
proteasome activator subunit 3 interacting protein 1, transcript variant X3
proteasome activator subunit 3 interacting protein 1, transcript variant X2
proteasome activator subunit 3 interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 14 bases in 14 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 14 bases in 14 codons; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
cholesteryl ester transfer protein, transcript variant X1
cholesteryl ester transfer protein, transcript variant X2
cholesteryl ester transfer protein, transcript variant X3
cholesteryl ester transfer protein isoform X2
cholesteryl ester transfer protein isoform X1
cholesteryl ester transfer protein isoform X3
homocysteine inducible ER protein with ubiquitin like domain 1
homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein
solute carrier family 12 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 12 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 12 member 3, transcript variant X1
solute carrier family 12 member 3 isoform X3
solute carrier family 12 member 3 isoform X2
solute carrier family 12 member 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
2-oxoglutarate and iron dependent oxygenase domain containing 1
cleavage and polyadenylation specificity factor subunit 5
G protein subunit alpha o1, transcript variant X3
G protein subunit alpha o1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha isoform X2
G protein subunit alpha o1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein G(o) subunit alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
carboxylesterase 1C-like, transcript variant X3
carboxylesterase 1C-like, transcript variant X2
carboxylesterase 1C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
sodium-dependent noradrenaline transporter
lysophosphatidylcholine acyltransferase 2, transcript variant X1
lysophosphatidylcholine acyltransferase 2, transcript variant X2
lysophosphatidylcholine acyltransferase 2 isoform X1
lysophosphatidylcholine acyltransferase 2 isoform X2
matrix metallopeptidase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
matrix metallopeptidase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
iroquois-class homeodomain protein IRX-6
iroquois homeobox 5, transcript variant X2
iroquois homeobox 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
iroquois-class homeodomain protein IRX-5 isoform X2
iroquois-class homeodomain protein IRX-5 isoform X1
iroquois homeobox 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
iroquois homeobox 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
iroquois-class homeodomain protein IRX-3 isoform X1
iroquois-class homeodomain protein IRX-3 isoform X2
FTO alpha-ketoglutarate dependent dioxygenase
alpha-ketoglutarate-dependent dioxygenase FTO
AKT interacting protein, transcript variant X1
AKT interacting protein, transcript variant X3
AKT interacting protein, transcript variant X2
RB transcriptional corepressor like 2, transcript variant X2
RB transcriptional corepressor like 2, transcript variant X1
retinoblastoma-like protein 2 isoform X2
retinoblastoma-like protein 2 isoform X1
chromodomain helicase DNA binding protein 9, transcript variant X6
chromodomain helicase DNA binding protein 9, transcript variant X1
chromodomain helicase DNA binding protein 9, transcript variant X4
chromodomain helicase DNA binding protein 9, transcript variant X5
chromodomain helicase DNA binding protein 9, transcript variant X3
chromodomain helicase DNA binding protein 9, transcript variant X2
chromodomain helicase DNA binding protein 9, transcript variant X7
chromodomain-helicase-DNA-binding protein 9 isoform X2
chromodomain-helicase-DNA-binding protein 9 isoform X1
chromodomain-helicase-DNA-binding protein 9 isoform X3
TOX high mobility group box family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC119802108, transcript variant X2
uncharacterized LOC119802108, transcript variant X1
spalt like transcription factor 1, transcript variant X3
spalt like transcription factor 1, transcript variant X2
spalt like transcription factor 1, transcript variant X1
CYLD lysine 63 deubiquitinase, transcript variant X5
CYLD lysine 63 deubiquitinase, transcript variant X4
CYLD lysine 63 deubiquitinase, transcript variant X1
CYLD lysine 63 deubiquitinase, transcript variant X7
CYLD lysine 63 deubiquitinase, transcript variant X6
CYLD lysine 63 deubiquitinase, transcript variant X2
CYLD lysine 63 deubiquitinase, transcript variant X3
ubiquitin carboxyl-terminal hydrolase CYLD isoform X3
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X4
nucleotide binding oligomerization domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nucleotide binding oligomerization domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nucleotide binding oligomerization domain containing 2, transcript variant X2
nucleotide-binding oligomerization domain-containing protein 2
NKD inhibitor of WNT signaling pathway 1
bromodomain containing 7, transcript variant X1
bromodomain containing 7, transcript variant X2
bromodomain-containing protein 7 isoform X1
bromodomain-containing protein 7 isoform X2
adenylate cyclase 7, transcript variant X3
adenylate cyclase 7, transcript variant X1
adenylate cyclase 7, transcript variant X2
adenylate cyclase 7, transcript variant X4
terminal nucleotidyltransferase 4B, transcript variant X2
terminal nucleotidyltransferase 4B, transcript variant X1
terminal nucleotidyltransferase 4B isoform X2
terminal nucleotidyltransferase 4B isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
CTD nuclear envelope phosphatase 1 regulatory subunit 1
nuclear envelope phosphatase-regulatory subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C16orf78 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
NEDD4 binding protein 1, transcript variant X1
NEDD4 binding protein 1, transcript variant X2
siah E3 ubiquitin protein ligase 1, transcript variant X3
siah E3 ubiquitin protein ligase 1, transcript variant X4
siah E3 ubiquitin protein ligase 1, transcript variant X2
siah E3 ubiquitin protein ligase 1, transcript variant X1
E3 ubiquitin-protein ligase SIAH1 isoform X1
E3 ubiquitin-protein ligase SIAH1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATP binding cassette subfamily C member 12, transcript variant X3
ATP binding cassette subfamily C member 12, transcript variant X1
ATP binding cassette subfamily C member 12, transcript variant X2
ATP binding cassette subfamily C member 12, transcript variant X4
ATP binding cassette subfamily C member 12, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATP-binding cassette sub-family C member 12 isoform X3
ATP-binding cassette sub-family C member 12 isoform X1
ATP-binding cassette sub-family C member 12 isoform X2
ATP-binding cassette sub-family C member 12 isoform X4
ATP binding cassette subfamily C member 12, transcript variant X6
ATP-binding cassette sub-family C member 12 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
phosphorylase kinase regulatory subunit beta, transcript variant X2
phosphorylase kinase regulatory subunit beta, transcript variant X1
phosphorylase kinase regulatory subunit beta, transcript variant X6
phosphorylase kinase regulatory subunit beta, transcript variant X3
phosphorylase kinase regulatory subunit beta, transcript variant X4
phosphorylase kinase regulatory subunit beta, transcript variant X7
phosphorylase kinase regulatory subunit beta, transcript variant X5
phosphorylase b kinase regulatory subunit beta isoform X2
phosphorylase b kinase regulatory subunit beta isoform X1
phosphorylase b kinase regulatory subunit beta isoform X3
phosphorylase b kinase regulatory subunit beta isoform X4
integrin alpha FG-GAP repeat containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member A2
chromosome 15 C16orf87 homolog, transcript variant X1
chromosome 15 C16orf87 homolog, transcript variant X2
UPF0547 protein C16orf87 homolog isoform X1
UPF0547 protein C16orf87 homolog isoform X2
vacuolar protein sorting-associated protein 35
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 30% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane protein 184C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 15% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
deoxyhypusine synthase, transcript variant X1
deoxyhypusine synthase, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14
F-box and WD repeat domain containing 9, transcript variant X2
F-box and WD repeat domain containing 9, transcript variant X1
F-box/WD repeat-containing protein 9 isoform X2
F-box/WD repeat-containing protein 9 isoform X1
F-box and WD repeat domain containing 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
F-box and WD repeat domain containing 9, transcript variant X4
F-box/WD repeat-containing protein 9 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00588
telomerase RNA component interacting RNase, transcript variant X3
telomerase RNA component interacting RNase, transcript variant X1
telomerase RNA component interacting RNase isoform X3
telomerase RNA component interacting RNase isoform X1
telomerase RNA component interacting RNase, transcript variant X2
telomerase RNA component interacting RNase isoform X2
guided entry of tail-anchored proteins factor 3, ATPase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
hook microtubule tethering protein 2, transcript variant X2
hook microtubule tethering protein 2, transcript variant X1
hook microtubule tethering protein 2, transcript variant X4
hook microtubule tethering protein 2, transcript variant X3
JunB proto-oncogene, AP-1 transcription factor subunit
thrombospondin type 1 domain containing 8
thrombospondin type-1 domain-containing protein 8
ribonuclease H2 subunit A, transcript variant X1
ribonuclease H2 subunit A, transcript variant X2
microtubule associated serine/threonine kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
microtubule-associated serine/threonine-protein kinase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
glutaryl-CoA dehydrogenase, mitochondrial
synaptonemal complex central element protein 2
phenylalanyl-tRNA synthetase subunit alpha
phenylalanine--tRNA ligase alpha subunit
RAD23 homolog A, nucleotide excision repair protein, transcript variant X3
RAD23 homolog A, nucleotide excision repair protein, transcript variant X1
RAD23 homolog A, nucleotide excision repair protein, transcript variant X2
UV excision repair protein RAD23 homolog A isoform X1
UV excision repair protein RAD23 homolog A isoform X2
UV excision repair protein RAD23 homolog A isoform X3
growth arrest and DNA damage-inducible proteins-interacting protein 1
DAN domain BMP antagonist family member 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor I X, transcript variant X1
nuclear factor I X, transcript variant X4
nuclear factor I X, transcript variant X3
nuclear factor I X, transcript variant X5
nuclear factor I X, transcript variant X2
LYL1 basic helix-loop-helix family member
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
tRNA methyltransferase 1, transcript variant X4
tRNA methyltransferase 1, transcript variant X6
tRNA methyltransferase 1, transcript variant X3
tRNA methyltransferase 1, transcript variant X1
tRNA methyltransferase 1, transcript variant X2
tRNA methyltransferase 1, transcript variant X5
tRNA (guanine(26)-N(2))-dimethyltransferase isoform X1
tRNA (guanine(26)-N(2))-dimethyltransferase isoform X2
nucleus accumbens associated 1, transcript variant X1
nucleus accumbens associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: voltage-dependent P/Q-type calcium channel subunit alpha-1A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
LOW QUALITY PROTEIN: transmembrane protein 184C
protein arginine N-methyltransferase 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein arginine N-methyltransferase 9, transcript variant X4
protein arginine N-methyltransferase 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein arginine N-methyltransferase 9, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein arginine N-methyltransferase 9 isoform X3
protein arginine N-methyltransferase 9, transcript variant X1
protein arginine N-methyltransferase 9 isoform X1
protein arginine N-methyltransferase 9, transcript variant X2
protein arginine N-methyltransferase 9 isoform X2
NADH:ubiquinone oxidoreductase subunit B7
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7
uncharacterized LOC119802096, transcript variant X2
uncharacterized LOC119802096, transcript variant X1
DnaJ heat shock protein family (Hsp40) member B1, transcript variant X1
dnaJ homolog subfamily B member 1 isoform X1
DnaJ heat shock protein family (Hsp40) member B1, transcript variant X2
dnaJ homolog subfamily B member 1 isoform X2
GIPC PDZ domain containing family member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
protein kinase N1, transcript variant X2
protein kinase N1, transcript variant X1
serine/threonine-protein kinase N1 isoform X2
serine/threonine-protein kinase N1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
DExD-box helicase 39A, transcript variant X1
ATP-dependent RNA helicase DDX39A isoform X1
DExD-box helicase 39A, transcript variant X2
ATP-dependent RNA helicase DDX39A isoform X2
adhesion G protein-coupled receptor E5, transcript variant X2
adhesion G protein-coupled receptor E5, transcript variant X4
adhesion G protein-coupled receptor E5, transcript variant X1
adhesion G protein-coupled receptor E5, transcript variant X3
adhesion G protein-coupled receptor E5, transcript variant X5
adhesion G protein-coupled receptor E5 isoform X5
adhesion G protein-coupled receptor E5 isoform X3
adhesion G protein-coupled receptor E5 isoform X2
adhesion G protein-coupled receptor E5 isoform X4
adhesion G protein-coupled receptor E5 isoform X1
adhesion G protein-coupled receptor L1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor L1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor L1, transcript variant X2
adhesion G protein-coupled receptor L1 isoform X1
adhesion G protein-coupled receptor L1 isoform X3
adhesion G protein-coupled receptor L1 isoform X2
adhesion G protein-coupled receptor L1, transcript variant X4
adhesion G protein-coupled receptor L1 isoform X4
anti-silencing function 1B histone chaperone
protein kinase cAMP-activated catalytic subunit alpha
cAMP-dependent protein kinase catalytic subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC119801906, transcript variant X2
uncharacterized LOC119801906, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil and C2 domain-containing protein 1A
break repair meiotic recombinase recruitment factor 1, transcript variant X3
break repair meiotic recombinase recruitment factor 1, transcript variant X2
break repair meiotic recombinase recruitment factor 1, transcript variant X1
break repair meiotic recombinase recruitment factor 1, transcript variant X4
break repair meiotic recombinase recruitment factor 1, transcript variant X5
break repair meiotic recombinase recruitment factor 1 isoform X1
break repair meiotic recombinase recruitment factor 1 isoform X2
break repair meiotic recombinase recruitment factor 1, transcript variant X6
break repair meiotic recombinase recruitment factor 1 isoform X3
nanos C2HC-type zinc finger 3, transcript variant X2
nanos C2HC-type zinc finger 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger SWIM domain-containing protein 4
leydig cell tumor 10 kDa protein homolog
methylthioribose-1-phosphate isomerase 1, transcript variant X2
methylthioribose-1-phosphate isomerase isoform X2
methylthioribose-1-phosphate isomerase 1, transcript variant X1
methylthioribose-1-phosphate isomerase isoform X1
YJU2 splicing factor homolog B, transcript variant X1
YJU2 splicing factor homolog B, transcript variant X3
YJU2 splicing factor homolog B, transcript variant X4
YJU2 splicing factor homolog B, transcript variant X2
coiled-coil domain-containing protein 130
transmembrane protein 184C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 184C, transcript variant X2
transmembrane protein 184C, transcript variant X1
transmembrane protein 184C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 4, transcription factor 2
RNA binding motif protein, X-linked-like-1
solute carrier family 10 member 7, transcript variant X5
sodium/bile acid cotransporter 7 isoform X5
solute carrier family 10 member 7, transcript variant X1
solute carrier family 10 member 7, transcript variant X2
solute carrier family 10 member 7, transcript variant X3
solute carrier family 10 member 7, transcript variant X4
solute carrier family 10 member 7, transcript variant X6
solute carrier family 10 member 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 10 member 7, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 10 member 7, transcript variant X8
solute carrier family 10 member 7, transcript variant X11
solute carrier family 10 member 7, transcript variant X9
solute carrier family 10 member 7, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
sodium/bile acid cotransporter 7 isoform X1
sodium/bile acid cotransporter 7 isoform X2
sodium/bile acid cotransporter 7 isoform X3
sodium/bile acid cotransporter 7 isoform X4
sodium/bile acid cotransporter 7 isoform X6
sodium/bile acid cotransporter 7 isoform X7
sodium/bile acid cotransporter 7 isoform X10
sodium/bile acid cotransporter 7 isoform X8
sodium/bile acid cotransporter 7 isoform X11
sodium/bile acid cotransporter 7 isoform X9
sodium/bile acid cotransporter 7 isoform X12
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X1
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X2
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X3
U6 snRNA-associated Sm-like protein LSm6
metabolism of cobalamin associated A, transcript variant X1
metabolism of cobalamin associated A, transcript variant X4
metabolism of cobalamin associated A, transcript variant X3
metabolism of cobalamin associated A, transcript variant X2
metabolism of cobalamin associated A, transcript variant X5
methylmalonic aciduria type A protein, mitochondrial isoform X2
methylmalonic aciduria type A protein, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mothers against decapentaplegic homolog 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins
OTU deubiquitinase 4, transcript variant X1
OTU deubiquitinase 4, transcript variant X2
OTU deubiquitinase 4, transcript variant X3
OTU domain-containing protein 4 isoform X1
OTU domain-containing protein 4 isoform X2
OTU domain-containing protein 4 isoform X3
ATP binding cassette subfamily E member 1
ATP-binding cassette sub-family E member 1
anaphase promoting complex subunit 10, transcript variant X1
anaphase promoting complex subunit 10, transcript variant X2
anaphase-promoting complex subunit 10 isoform X1
anaphase-promoting complex subunit 10 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119802093, transcript variant X3
uncharacterized LOC119802093, transcript variant X1
uncharacterized LOC119802093, transcript variant X4
uncharacterized LOC119802093, transcript variant X5
uncharacterized LOC119802093, transcript variant X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5
protein arginine N-methyltransferase 9-like, transcript variant X2
protein arginine N-methyltransferase 9-like, transcript variant X1
protein arginine N-methyltransferase 9-like, transcript variant X3
protein arginine N-methyltransferase 9-like, transcript variant X4
protein arginine N-methyltransferase 9-like, transcript variant X6
protein arginine N-methyltransferase 9-like isoform X2
protein arginine N-methyltransferase 9-like isoform X1
protein arginine N-methyltransferase 9-like isoform X3
protein arginine N-methyltransferase 9-like isoform X4
protein arginine N-methyltransferase 9-like, transcript variant X5
GRB2 associated binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GRB2 associated binding protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GRB2-associated-binding protein 1 isoform X2
GRB2-associated-binding protein 1 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 38
inositol polyphosphate-4-phosphatase type II B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inositol polyphosphate-4-phosphatase type II B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inositol polyphosphate 4-phosphatase type II isoform X1
inositol polyphosphate 4-phosphatase type II isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119801981, transcript variant X1
uncharacterized LOC119801981, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
mitochondrial brown fat uncoupling protein 1
ELMO domain containing 2, transcript variant X1
ELMO domain containing 2, transcript variant X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
short coiled-coil protein, transcript variant X1
short coiled-coil protein, transcript variant X2
LOW QUALITY PROTEIN: protein arginine N-methyltransferase 9
transmembrane protein 184C-like, transcript variant X1
transmembrane protein 184C-like, transcript variant X2
transmembrane protein 184C-like isoform X1
transmembrane protein 184C-like isoform X2
Rho GTPase activating protein 10, transcript variant X1
Rho GTPase activating protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Rho GTPase activating protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 10 isoform X1
rho GTPase-activating protein 10 isoform X2
rho GTPase-activating protein 10 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins
ubiquitin-60S ribosomal protein L40-like isoform X1
nuclear receptor subfamily 3 group C member 2, transcript variant X6
nuclear receptor subfamily 3 group C member 2, transcript variant X4
nuclear receptor subfamily 3 group C member 2, transcript variant X7
nuclear receptor subfamily 3 group C member 2, transcript variant X1
nuclear receptor subfamily 3 group C member 2, transcript variant X2
nuclear receptor subfamily 3 group C member 2, transcript variant X3
nuclear receptor subfamily 3 group C member 2, transcript variant X5
LOW QUALITY PROTEIN: protein FAM32A-like
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
minichromosome maintenance complex component 5
target of myb1 membrane trafficking protein, transcript variant X1
target of myb1 membrane trafficking protein, transcript variant X4
target of myb1 membrane trafficking protein, transcript variant X3
target of myb1 membrane trafficking protein, transcript variant X2
HMG-box containing 4, transcript variant X2
HMG-box containing 4, transcript variant X1
HMG-box containing 4, transcript variant X4
HMG-box containing 4, transcript variant X3
HMG domain-containing protein 4 isoform X1
HMG domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 40% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: kelch domain-containing protein 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: junctophilin-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
LARGE xylosyl- and glucuronyltransferase 1, transcript variant X1
LARGE xylosyl- and glucuronyltransferase 1, transcript variant X2
LARGE xylosyl- and glucuronyltransferase 1, transcript variant X3
LARGE xylosyl- and glucuronyltransferase 1, transcript variant X5
LARGE xylosyl- and glucuronyltransferase 1, transcript variant X4
LARGE xylosyl- and glucuronyltransferase 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00598
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
RNA guanine-N7 methyltransferase activating subunit-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
CKLF-like MARVEL transmembrane domain-containing protein 2B
CKLF-like MARVEL transmembrane domain-containing protein 2A
CKLF like MARVEL transmembrane domain containing 3, transcript variant X2
CKLF like MARVEL transmembrane domain containing 3, transcript variant X1
CKLF like MARVEL transmembrane domain containing 3, transcript variant X3
CKLF like MARVEL transmembrane domain containing 3, transcript variant X4
CKLF-like MARVEL transmembrane domain-containing protein 3 isoform X2
CKLF-like MARVEL transmembrane domain-containing protein 3 isoform X1
CKLF like MARVEL transmembrane domain containing 4
CKLF-like MARVEL transmembrane domain-containing protein 4
dynein cytoplasmic 1 light intermediate chain 2, transcript variant X1
dynein cytoplasmic 1 light intermediate chain 2, transcript variant X2
cytoplasmic dynein 1 light intermediate chain 2 isoform X1
cytoplasmic dynein 1 light intermediate chain 2 isoform X2
telomere repeat binding bouquet formation protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
telomere repeats-binding bouquet formation protein 1
NEDD8-activating enzyme E1 regulatory subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X1
pyruvate dehyrogenase phosphatase catalytic subunit 2, transcript variant X2
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 2, mitochondrial
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
cytosolic iron-sulfur assembly component 2B
acylcarnitine hydrolase-like, transcript variant X3
acylcarnitine hydrolase-like, transcript variant X2
acylcarnitine hydrolase-like, transcript variant X7
acylcarnitine hydrolase-like, transcript variant X6
acylcarnitine hydrolase-like, transcript variant X4
acylcarnitine hydrolase-like, transcript variant X1
acylcarnitine hydrolase-like, transcript variant X5
liver carboxylesterase-like, transcript variant X2
liver carboxylesterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor of activated T cells 5, transcript variant X1
nuclear factor of activated T cells 5, transcript variant X4
nuclear factor of activated T cells 5, transcript variant X3
nuclear factor of activated T cells 5, transcript variant X2
nuclear factor of activated T cells 5, transcript variant X5
nuclear factor of activated T cells 5, transcript variant X6
nuclear factor of activated T cells 5, transcript variant X7
nuclear factor of activated T-cells 5 isoform X4
nuclear factor of activated T-cells 5 isoform X3
nuclear factor of activated T-cells 5 isoform X2
nuclear factor of activated T-cells 5 isoform X1
nuclear factor of activated T-cells 5 isoform X5
nuclear factor of activated T-cells 5 isoform X6
nuclear factor of activated T-cells 5 isoform X7
telomeric repeat binding factor 2, transcript variant X1
telomeric repeat binding factor 2, transcript variant X2
telomeric repeat-binding factor 2 isoform X1
telomeric repeat-binding factor 2 isoform X2
transmembrane p24 trafficking protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane p24 trafficking protein 6, transcript variant X2
transmembrane p24 trafficking protein 6, transcript variant X3
transmembrane emp24 domain-containing protein 6 isoform X1
transmembrane emp24 domain-containing protein 6 isoform X2
transmembrane emp24 domain-containing protein 6 isoform X3
nucleolar pre-rRNA processing protein NIP7
60S ribosome subunit biogenesis protein NIP7 homolog
component of oligomeric golgi complex 8, transcript variant X4
component of oligomeric golgi complex 8, transcript variant X3
component of oligomeric golgi complex 8, transcript variant X1
conserved oligomeric Golgi complex subunit 8 isoform X4
conserved oligomeric Golgi complex subunit 8 isoform X3
conserved oligomeric Golgi complex subunit 8 isoform X1
component of oligomeric golgi complex 8, transcript variant X2
conserved oligomeric Golgi complex subunit 8 isoform X2
vacuolar protein sorting-associated protein 4A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UTP4 small subunit processome component, transcript variant X2
UTP4 small subunit processome component, transcript variant X1
UTP4 small subunit processome component, transcript variant X3
U3 small nucleolar RNA-associated protein 4 homolog
chromosome transmission fidelity factor 8
chromosome transmission fidelity protein 8 homolog
DERPC proline and glycine rich nuclear protein
decreased expression in renal and prostate cancer protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transport and golgi organization 6 homolog, transcript variant X3
transport and golgi organization 6 homolog, transcript variant X2
transport and golgi organization 6 homolog, transcript variant X4
transport and golgi organization 6 homolog, transcript variant X1
transport and Golgi organization protein 6 homolog isoform X3
transport and Golgi organization protein 6 homolog isoform X2
transport and Golgi organization protein 6 homolog isoform X4
transport and Golgi organization protein 6 homolog isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tissue alpha-L-fucosidase-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: melanoma-associated antigen B18-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sphingomyelin phosphodiesterase 3, transcript variant X2
sphingomyelin phosphodiesterase 3, transcript variant X1
protein arginine methyltransferase 7, transcript variant X2
protein arginine methyltransferase 7, transcript variant X1
protein arginine N-methyltransferase 7 isoform X1
protein arginine N-methyltransferase 7 isoform X2
solute carrier family 7 member 6 opposite strand, transcript variant X1
solute carrier family 7 member 6 opposite strand, transcript variant X2
probable RNA polymerase II nuclear localization protein SLC7A6OS
solute carrier family 7 member 6, transcript variant X1
solute carrier family 7 member 6, transcript variant X2
solute carrier family 7 member 6, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phospholipase A2 group XV
epithelial splicing regulatory protein 2, transcript variant X2
epithelial splicing regulatory protein 2, transcript variant X1
epithelial splicing regulatory protein 2 isoform X1
epithelial splicing regulatory protein 2 isoform X2
nuclear factor of activated T cells 3, transcript variant X1
nuclear factor of activated T cells 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nuclear factor of activated T-cells, cytoplasmic 3 isoform X1
nuclear factor of activated T-cells, cytoplasmic 3 isoform X2
dihydrouridine synthase 2, transcript variant X2
dihydrouridine synthase 2, transcript variant X1
dihydrouridine synthase 2, transcript variant X3
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X2
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X1
tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 10 bases in 8 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 10 bases in 8 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable ATP-dependent RNA helicase DDX28
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 12 member 4, transcript variant X1
solute carrier family 12 member 4 isoform X1
solute carrier family 12 member 4, transcript variant X2
solute carrier family 12 member 4 isoform X2
phosphatidylcholine-sterol acyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
enhancer of mRNA decapping 4, transcript variant X5
enhancer of mRNA decapping 4, transcript variant X4
enhancer of mRNA decapping 4, transcript variant X3
enhancer of mRNA decapping 4, transcript variant X2
enhancer of mRNA decapping 4, transcript variant X6
enhancer of mRNA decapping 4, transcript variant X1
enhancer of mRNA decapping 4, transcript variant X7
enhancer of mRNA-decapping protein 4 isoform X5
enhancer of mRNA-decapping protein 4 isoform X4
enhancer of mRNA-decapping protein 4 isoform X3
enhancer of mRNA-decapping protein 4 isoform X2
enhancer of mRNA-decapping protein 4 isoform X6
enhancer of mRNA-decapping protein 4 isoform X1
enhancer of mRNA-decapping protein 4 isoform X7
nuclear transport factor 2, transcript variant X1
nuclear transport factor 2, transcript variant X2
centromere protein T, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
centromere protein T, transcript variant X2
translin associated factor X interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
translin-associated factor X-interacting protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucose-fructose oxidoreductase domain containing 2
glucose-fructose oxidoreductase domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C16orf86 homolog
enkurin domain containing 1, transcript variant X1
enkurin domain containing 1, transcript variant X2
par-6 family cell polarity regulator alpha, transcript variant X3
par-6 family cell polarity regulator alpha, transcript variant X1
par-6 family cell polarity regulator alpha, transcript variant X2
partitioning defective 6 homolog alpha isoform X3
partitioning defective 6 homolog alpha isoform X2
partitioning defective 6 homolog alpha isoform X1
ACD shelterin complex subunit and telomerase recruitment factor
adrenocortical dysplasia protein homolog
capping protein regulator and myosin 1 linker 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
capping protein, Arp2/3 and myosin-I linker protein 2
CCCTC-binding factor, transcript variant X2
CCCTC-binding factor, transcript variant X1
transcriptional repressor CTCF isoform X2
transcriptional repressor CTCF isoform X1
agouti related neuropeptide, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
agouti related neuropeptide, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
agouti related neuropeptide, transcript variant X3
RHO family interacting cell polarization regulator 1, transcript variant X1
RHO family interacting cell polarization regulator 1, transcript variant X2
RHO family interacting cell polarization regulator 1, transcript variant X3
rho family-interacting cell polarization regulator 1 isoform X2
rho family-interacting cell polarization regulator 1 isoform X1
rho family-interacting cell polarization regulator 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
corticosteroid 11-beta-dehydrogenase isozyme 2
zinc finger DHHC-type containing 1, transcript variant X1
zinc finger DHHC-type containing 1, transcript variant X3
zinc finger DHHC-type containing 1, transcript variant X2
zinc finger DHHC-type containing 1, transcript variant X4
zinc finger DHHC-type containing 1, transcript variant X5
zinc finger DHHC-type containing 1, transcript variant X6
tubulin polymerization promoting protein family member 3
tubulin polymerization-promoting protein family member 3
leucine rich repeat containing 36, transcript variant X1
leucine rich repeat containing 36, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 36 isoform X1
leucine-rich repeat-containing protein 36 isoform X2
potassium channel tetramerization domain containing 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 5% coverage of the annotated genomic feature by RNAseq alignments
BTB/POZ domain-containing protein KCTD19
pleckstrin homology and RhoGEF domain containing G4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat containing 29, transcript variant X1
leucine rich repeat containing 29, transcript variant X3
leucine rich repeat containing 29, transcript variant X4
leucine-rich repeat-containing protein 29 isoform X1
leucine-rich repeat-containing protein 29 isoform X3
leucine rich repeat containing 29, transcript variant X2
leucine-rich repeat-containing protein 29 isoform X2
leucine-rich repeat-containing protein 29 isoform X4
exocyst complex component 3 like 1, transcript variant X3
exocyst complex component 3 like 1, transcript variant X2
exocyst complex component 3 like 1, transcript variant X1
exocyst complex component 3-like protein isoform X1
exocyst complex component 3-like protein isoform X2
exocyst complex component 3 like 1, transcript variant X4
exocyst complex component 3-like protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein KIAA0895-like homolog
nucleolar protein 3, transcript variant X2
nucleolar protein 3, transcript variant X1
heat shock transcription factor 4, transcript variant X9
heat shock transcription factor 4, transcript variant X4
heat shock transcription factor 4, transcript variant X3
heat shock transcription factor 4, transcript variant X6
heat shock transcription factor 4, transcript variant X1
heat shock transcription factor 4, transcript variant X10
heat shock transcription factor 4, transcript variant X2
heat shock transcription factor 4, transcript variant X5
heat shock transcription factor 4, transcript variant X7
heat shock transcription factor 4, transcript variant X8
F-box and leucine rich repeat protein 8, transcript variant X1
F-box and leucine rich repeat protein 8, transcript variant X2
TNFRSF1A associated via death domain, transcript variant X1
TNFRSF1A associated via death domain, transcript variant X2
tumor necrosis factor receptor type 1-associated DEATH domain protein
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
core-binding factor subunit beta, transcript variant X1
core-binding factor subunit beta, transcript variant X2
core-binding factor subunit beta isoform X1
core-binding factor subunit beta isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
carboxylesterase 3, transcript variant X4
carboxylesterase 3, transcript variant X2
carboxylesterase 3, transcript variant X3
carboxylesterase 3, transcript variant X1
carboxylesterase 3, transcript variant X5
pyrethroid hydrolase Ces2e-like, transcript variant X1
pyrethroid hydrolase Ces2e-like, transcript variant X2
pyrethroid hydrolase Ces2e-like isoform X1
pyrethroid hydrolase Ces2e-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pyrethroid hydrolase Ces2e-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
pyrethroid hydrolase Ces2e-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
telomeric repeat-binding factor 2-interacting protein 1
lysyl-tRNA synthetase 1, transcript variant X1
lysyl-tRNA synthetase 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 7 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 7 bases in 5 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tRNA-specific adenosine deaminase 1
GABA type A receptor associated protein like 2
gamma-aminobutyric acid receptor-associated protein-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 170A, transcript variant X1
transmembrane protein 170A, transcript variant X2
transmembrane protein 170A, transcript variant X3
BCAR1 scaffold protein, Cas family member, transcript variant X3
BCAR1 scaffold protein, Cas family member, transcript variant X1
breast cancer anti-estrogen resistance protein 1 isoform X1
BCAR1 scaffold protein, Cas family member, transcript variant X2
breast cancer anti-estrogen resistance protein 1 isoform X2
BCAR1 scaffold protein, Cas family member, transcript variant X4
breast cancer anti-estrogen resistance protein 1 isoform X3
ZFP1 zinc finger protein, transcript variant X7
ZFP1 zinc finger protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ZFP1 zinc finger protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ZFP1 zinc finger protein, transcript variant X2
ZFP1 zinc finger protein, transcript variant X5
ZFP1 zinc finger protein, transcript variant X3
ZFP1 zinc finger protein, transcript variant X1
zinc finger protein 1 homolog isoform X4
zinc finger protein 1 homolog isoform X3
zinc finger protein 1 homolog isoform X2
zinc finger protein 1 homolog isoform X1
lactate dehydrogenase D, transcript variant X1
lactate dehydrogenase D, transcript variant X2
probable D-lactate dehydrogenase, mitochondrial isoform X1
probable D-lactate dehydrogenase, mitochondrial isoform X2
zinc and ring finger 1, transcript variant X1
zinc and ring finger 1, transcript variant X2
WD repeat domain 59, transcript variant X1
WD repeat domain 59, transcript variant X2
WD repeat domain 59, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mixed lineage kinase domain like pseudokinase, transcript variant X2
mixed lineage kinase domain like pseudokinase, transcript variant X1
mixed lineage kinase domain-like protein
ring finger and WD repeat domain 3, transcript variant X1
ring finger and WD repeat domain 3, transcript variant X2
E3 ubiquitin-protein ligase RFWD3 isoform X1
E3 ubiquitin-protein ligase RFWD3 isoform X2
pyruvate dehydrogenase phosphatase regulatory subunit
pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: C-type lectin domain family 18 member C
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
alanyl-tRNA synthetase 1, transcript variant X3
alanyl-tRNA synthetase 1, transcript variant X1
alanyl-tRNA synthetase 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 3 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ATP-dependent RNA helicase DDX19B-like
ST3 beta-galactoside alpha-2,3-sialyltransferase 2
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 2
component of oligomeric golgi complex 4, transcript variant X2
component of oligomeric golgi complex 4, transcript variant X1
component of oligomeric golgi complex 4, transcript variant X3
conserved oligomeric Golgi complex subunit 4 isoform X2
conserved oligomeric Golgi complex subunit 4 isoform X1
splicing factor 3b subunit 3, transcript variant X2
splicing factor 3b subunit 3, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00611
MTSS I-BAR domain containing 2, transcript variant X5
MTSS I-BAR domain containing 2, transcript variant X2
MTSS I-BAR domain containing 2, transcript variant X4
MTSS I-BAR domain containing 2, transcript variant X3
MTSS I-BAR domain containing 2, transcript variant X1
HYDIN axonemal central pair apparatus protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119801782, transcript variant X1
uncharacterized LOC119801782, transcript variant X2
uncharacterized LOC119801782, transcript variant X3
uncharacterized LOC119801782, transcript variant X4
uncharacterized LOC119801782, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2
zinc finger protein 23, transcript variant X1
zinc finger protein 23, transcript variant X2
zinc finger protein 23, transcript variant X3
zinc finger protein 23, transcript variant X4
carbohydrate sulfotransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
carbohydrate sulfotransferase 4, transcript variant X1
carbohydrate sulfotransferase 4, transcript variant X4
carbohydrate sulfotransferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MARVEL domain containing 3, transcript variant X1
MARVEL domain containing 3, transcript variant X2
MARVEL domain containing 3, transcript variant X3
MARVEL domain-containing protein 3 isoform X1
MARVEL domain-containing protein 3 isoform X2
MARVEL domain-containing protein 3 isoform X3
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X1
PH domain and leucine rich repeat protein phosphatase 2, transcript variant X2
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X1
PH domain leucine-rich repeat-containing protein phosphatase 2 isoform X2
adaptor related protein complex 1 subunit gamma 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: AP-1 complex subunit gamma-1
COORDINATES: nucleotide motif:Rfam:12.0:RF00423
COORDINATES: nucleotide motif:Rfam:12.0:RF00576
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 821, transcript variant X3
zinc finger protein 821, transcript variant X9
zinc finger protein 821, transcript variant X8
zinc finger protein 821, transcript variant X4
zinc finger protein 821, transcript variant X7
zinc finger protein 821, transcript variant X5
zinc finger protein 821, transcript variant X6
zinc finger protein 821, transcript variant X2
zinc finger protein 821, transcript variant X1
zinc finger protein 821, transcript variant X10
IST1 factor associated with ESCRT-III, transcript variant X1
IST1 factor associated with ESCRT-III, transcript variant X2
polycystin 1 like 3, transient receptor potential channel interacting
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
polycystic kidney disease protein 1-like 3
dihydroorotate dehydrogenase (quinone), transcript variant X2
dihydroorotate dehydrogenase (quinone), mitochondrial isoform X2
dihydroorotate dehydrogenase (quinone), transcript variant X1
dihydroorotate dehydrogenase (quinone), mitochondrial isoform X1
thioredoxin like 4B, transcript variant X4
thioredoxin like 4B, transcript variant X1
thioredoxin like 4B, transcript variant X3
thioredoxin like 4B, transcript variant X2
pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16
polyamine modulated factor 1 binding protein 1
polyamine-modulated factor 1-binding protein 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: dnaJ homolog subfamily B member 6-like
zinc finger homeobox 3, transcript variant X2
zinc finger homeobox 3, transcript variant X1
zinc finger homeobox protein 3 isoform X1
zinc finger homeobox protein 3 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01277
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
26S proteasome non-ATPase regulatory subunit 7
WW domain containing E3 ubiquitin protein ligase 2
NEDD4-like E3 ubiquitin-protein ligase WWP2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
contactin associated protein family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
contactin-associated protein-like 4 isoform X1
contactin associated protein family member 4, transcript variant X3
contactin associated protein family member 4, transcript variant X6
contactin associated protein family member 4, transcript variant X5
contactin associated protein family member 4, transcript variant X4
contactin associated protein family member 4, transcript variant X2
contactin-associated protein-like 4 isoform X3
contactin-associated protein-like 4 isoform X6
contactin-associated protein-like 4 isoform X5
contactin-associated protein-like 4 isoform X4
contactin-associated protein-like 4 isoform X2
MON1 homolog B, secretory trafficking associated
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 10 bases in 7 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 10 bases in 7 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: vacuolar fusion protein MON1 homolog B
synaptonemal complex central element protein 1 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
synaptonemal complex central element protein 1-like
ADAM metallopeptidase with thrombospondin type 1 motif 18
A disintegrin and metalloproteinase with thrombospondin motifs 18
nudix hydrolase 7, transcript variant X1
nudix hydrolase 7, transcript variant X2
peroxisomal coenzyme A diphosphatase NUDT7 isoform X1
peroxisomal coenzyme A diphosphatase NUDT7 isoform X2
synaptic vesicle membrane protein VAT-1 homolog-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
WW domain containing oxidoreductase, transcript variant X2
WW domain containing oxidoreductase, transcript variant X3
WW domain containing oxidoreductase, transcript variant X4
WW domain containing oxidoreductase, transcript variant X1
WW domain-containing oxidoreductase isoform X1
WW domain-containing oxidoreductase isoform X4
WW domain-containing oxidoreductase isoform X2
WW domain-containing oxidoreductase isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription factor Maf
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
C-X9-C motif containing 2, transcript variant X3
C-X9-C motif containing 2, transcript variant X4
C-X9-C motif containing 2, transcript variant X2
C-X9-C motif containing 2, transcript variant X1
COX assembly mitochondrial protein 2 homolog isoform X3
COX assembly mitochondrial protein 2 homolog isoform X2
COX assembly mitochondrial protein 2 homolog isoform X1
COX assembly mitochondrial protein 2 homolog isoform X4
centromere protein N, transcript variant X2
centromere protein N, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chromosome 15 C16orf46 homolog, transcript variant X2
uncharacterized protein C16orf46 homolog isoform X2
chromosome 15 C16orf46 homolog, transcript variant X1
uncharacterized protein C16orf46 homolog isoform X1
chromosome 15 C16orf46 homolog, transcript variant X3
uncharacterized protein C16orf46 homolog isoform X3
glycine cleavage system H protein, mitochondrial
polycystic kidney disease protein 1-like 2
beta-carotene oxygenase 1, transcript variant X3
beta-carotene oxygenase 1, transcript variant X1
beta-carotene oxygenase 1, transcript variant X2
beta,beta-carotene 15,15'-dioxygenase isoform X1
beta,beta-carotene 15,15'-dioxygenase isoform X2
beta,beta-carotene 15,15'-dioxygenase isoform X3
beta-carotene oxygenase 1, transcript variant X4
beta,beta-carotene 15,15'-dioxygenase isoform X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X1
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X3
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X2
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X4
short chain dehydrogenase/reductase family 42E, member 1, transcript variant X5
short-chain dehydrogenase/reductase family 42E member 1
hydroxysteroid 17-beta dehydrogenase 2, transcript variant X3
hydroxysteroid 17-beta dehydrogenase 2, transcript variant X2
hydroxysteroid 17-beta dehydrogenase 2, transcript variant X1
17-beta-hydroxysteroid dehydrogenase type 2 isoform X2
17-beta-hydroxysteroid dehydrogenase type 2 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00432
COORDINATES: nucleotide motif:Rfam:12.0:RF00322
malonyl-CoA decarboxylase, mitochondrial
uncharacterized LOC119802009, transcript variant X1
uncharacterized LOC119802009, transcript variant X3
uncharacterized LOC119802009, transcript variant X2
oxidative stress induced growth inhibitor 1
oxidative stress-induced growth inhibitor 1
N-terminal EF-hand calcium binding protein 2
N-terminal EF-hand calcium-binding protein 2
putative sodium-coupled neutral amino acid transporter 8
membrane bound transcription factor peptidase, site 1, transcript variant X2
membrane bound transcription factor peptidase, site 1, transcript variant X3
membrane bound transcription factor peptidase, site 1, transcript variant X1
membrane-bound transcription factor site-1 protease isoform X3
membrane-bound transcription factor site-1 protease isoform X2
membrane-bound transcription factor site-1 protease isoform X1
inactive hydroxysteroid dehydrogenase-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
TATA-box binding protein associated factor, RNA polymerase I subunit C, transcript variant X1
TATA-box binding protein associated factor, RNA polymerase I subunit C, transcript variant X2
TATA-box binding protein associated factor, RNA polymerase I subunit C, transcript variant X3
TATA-box binding protein associated factor, RNA polymerase I subunit C, transcript variant X4
TATA box-binding protein-associated factor RNA polymerase I subunit C isoform X1
TATA box-binding protein-associated factor RNA polymerase I subunit C isoform X2
TATA box-binding protein-associated factor RNA polymerase I subunit C isoform X3
TATA box-binding protein-associated factor RNA polymerase I subunit C isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
adenosine deaminase domain-containing protein 2
potassium voltage-gated channel modifier subfamily G member 4
potassium voltage-gated channel subfamily G member 4
WAP four-disulfide core domain protein 1
ATPase secretory pathway Ca2+ transporting 2
calcium-transporting ATPase type 2C member 2
MTOR associated protein, eak-7 homolog, transcript variant X1
MTOR associated protein, eak-7 homolog, transcript variant X2
coactosin like F-actin binding protein 1
kelch like family member 36, transcript variant X2
kelch like family member 36, transcript variant X1
ubiquitin specific peptidase 10, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 10 isoform X3
ubiquitin specific peptidase 10, transcript variant X1
ubiquitin specific peptidase 10, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 10 isoform X1
ubiquitin carboxyl-terminal hydrolase 10 isoform X2
cysteine rich secretory protein LCCL domain containing 2
cysteine-rich secretory protein LCCL domain-containing 2
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 7, transcript variant X2
KIAA0513 ortholog, transcript variant X2
KIAA0513 ortholog, transcript variant X1
uncharacterized protein KIAA0513 homolog
CBY1 interacting BAR domain containing 2
CBY1-interacting BAR domain-containing protein 2
Gse1 coiled-coil protein, transcript variant X4
Gse1 coiled-coil protein, transcript variant X2
Gse1 coiled-coil protein, transcript variant X1
Gse1 coiled-coil protein, transcript variant X3
Gse1 coiled-coil protein, transcript variant X7
Gse1 coiled-coil protein, transcript variant X10
Gse1 coiled-coil protein, transcript variant X9
Gse1 coiled-coil protein, transcript variant X6
Gse1 coiled-coil protein, transcript variant X8
Gse1 coiled-coil protein, transcript variant X11
Gse1 coiled-coil protein, transcript variant X5
DNA replication complex GINS protein PSF2
ER membrane protein complex subunit 8, transcript variant X4
ER membrane protein complex subunit 8, transcript variant X3
ER membrane protein complex subunit 8 isoform X4
ER membrane protein complex subunit 8 isoform X3
ER membrane protein complex subunit 8, transcript variant X1
ER membrane protein complex subunit 8 isoform X1
ER membrane protein complex subunit 8, transcript variant X2
ER membrane protein complex subunit 8 isoform X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X1
cytochrome c oxidase subunit 4 isoform 1, mitochondrial, transcript variant X2
cytochrome c oxidase subunit 4 isoform 1, mitochondrial
interferon regulatory factor 8, transcript variant X1
interferon regulatory factor 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
interferon regulatory factor 8, transcript variant X3
methenyltetrahydrofolate synthetase domain containing
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: methenyltetrahydrofolate synthase domain-containing protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 4 codons; deleted 5 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 4 codons; deleted 5 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: forkhead box protein C2
chromosome 15 C16orf95 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chromosome 15 C16orf95 homolog, transcript variant X2
uncharacterized protein C16orf95 homolog isoform X1
uncharacterized protein C16orf95 homolog isoform X2
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
microtubule associated protein 1 light chain 3 beta
microtubule-associated proteins 1A/1B light chain 3B
zinc finger CCHC-type containing 14, transcript variant X4
zinc finger CCHC-type containing 14, transcript variant X3
zinc finger CCHC-type containing 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger CCHC-type containing 14, transcript variant X1
zinc finger CCHC domain-containing protein 14 isoform X2
zinc finger CCHC domain-containing protein 14 isoform X3
zinc finger CCHC domain-containing protein 14 isoform X1
kelch domain containing 4, transcript variant X1
kelch domain containing 4, transcript variant X3
kelch domain containing 4, transcript variant X2
kelch domain-containing protein 4 isoform X1
kelch domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
large neutral amino acids transporter small subunit 1
BTG3 associated nuclear protein, transcript variant X1
BTG3 associated nuclear protein, transcript variant X5
BTG3 associated nuclear protein, transcript variant X2
BTG3 associated nuclear protein, transcript variant X6
BTG3 associated nuclear protein, transcript variant X3
BTG3 associated nuclear protein, transcript variant X4
BTG3 associated nuclear protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein, FOG family member 1, transcript variant X2
zinc finger protein, FOG family member 1, transcript variant X5
zinc finger protein, FOG family member 1, transcript variant X4
zinc finger protein, FOG family member 1, transcript variant X1
zinc finger protein, FOG family member 1, transcript variant X3
thyrotropin-releasing hormone receptor-like
zinc finger CCCH-type containing 18, transcript variant X1
zinc finger CCCH-type containing 18, transcript variant X3
zinc finger CCCH-type containing 18, transcript variant X2
zinc finger CCCH domain-containing protein 18 isoform X1
zinc finger CCCH domain-containing protein 18 isoform X2
snail family transcriptional repressor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
piezo type mechanosensitive ion channel component 1, transcript variant X2
piezo type mechanosensitive ion channel component 1, transcript variant X3
piezo type mechanosensitive ion channel component 1, transcript variant X1
piezo-type mechanosensitive ion channel component 1 isoform X2
piezo-type mechanosensitive ion channel component 1 isoform X3
piezo-type mechanosensitive ion channel component 1 isoform X1
chromatin licensing and DNA replication factor 1
trafficking protein particle complex subunit 2L
trafficking protein particle complex subunit 2-like protein
embryonic polyadenylate-binding protein 2
CBFA2/RUNX1 partner transcriptional co-repressor 3
acyl-CoA synthetase family member 3, transcript variant X1
acyl-CoA synthetase family member 3, transcript variant X2
malonate--CoA ligase ACSF3, mitochondrial isoform X1
malonate--CoA ligase ACSF3, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 11, transcript variant X2
ankyrin repeat domain 11, transcript variant X1
ankyrin repeat domain 11, transcript variant X3
ankyrin repeat domain-containing protein 11 isoform X2
ankyrin repeat domain-containing protein 11 isoform X1
ankyrin repeat domain-containing protein 11 isoform X3
SPG7 matrix AAA peptidase subunit, paraplegin, transcript variant X2
SPG7 matrix AAA peptidase subunit, paraplegin, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00324
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
sulfotransferase 2A1-like, transcript variant X1
sulfotransferase 2A1-like, transcript variant X2
sulfotransferase 2A1-like, transcript variant X3
sulfotransferase 2A1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
cyclin dependent kinase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin dependent kinase 10, transcript variant X3
cyclin dependent kinase 10, transcript variant X2
cyclin dependent kinase 10, transcript variant X4
spermatogenesis associated 2 like, transcript variant X3
spermatogenesis associated 2 like, transcript variant X1
spermatogenesis associated 2 like, transcript variant X2
spermatogenesis-associated protein 2-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 25, transcript variant X2
transcription factor 25, transcript variant X3
transcription factor 25, transcript variant X4
transcription factor 25, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
differentially expressed in FDCP 8 homolog, transcript variant X1
differentially expressed in FDCP 8 homolog, transcript variant X2
differentially expressed in FDCP 8 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: dysbindin domain-containing protein 1
growth arrest specific 8, transcript variant X1
growth arrest specific 8, transcript variant X2
dynein regulatory complex subunit 4 isoform X1
dynein regulatory complex subunit 4 isoform X2
growth arrest specific 8, transcript variant X3
dynein regulatory complex subunit 4 isoform X3
zinc finger protein 120-like, transcript variant X9
zinc finger protein 120-like, transcript variant X1
zinc finger protein 120-like, transcript variant X6
zinc finger protein 120-like, transcript variant X4
zinc finger protein 120-like, transcript variant X8
zinc finger protein 120-like, transcript variant X3
zinc finger protein 120-like, transcript variant X7
zinc finger protein 120-like, transcript variant X2
zinc finger protein 120-like, transcript variant X5
zinc finger protein 120-like, transcript variant X10
zinc finger protein 431-like, transcript variant X1
zinc finger protein 431-like, transcript variant X2
zinc finger protein 431-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 431-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho-related GTP-binding protein RhoU
uncharacterized LOC119802051, transcript variant X2
uncharacterized LOC119802051, transcript variant X1
uncharacterized LOC119802051, transcript variant X3
centriole, cilia and spindle associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centriole, cilia and spindle-associated protein
actin alpha 1, skeletal muscle, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
actin alpha 1, skeletal muscle, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
ATP binding cassette subfamily B member 10
ATP-binding cassette sub-family B member 10, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00416
TATA-box binding protein associated factor 5 like, transcript variant X1
TATA-box binding protein associated factor 5 like, transcript variant X2
TATA-box binding protein associated factor 5 like, transcript variant X3
TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L
unhealthy ribosome biogenesis protein 2 homolog
polypeptide N-acetylgalactosaminyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 5
conserved oligomeric Golgi complex subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein C1orf198 homolog
tetratricopeptide repeat domain 13, transcript variant X7
tetratricopeptide repeat domain 13, transcript variant X6
tetratricopeptide repeat domain 13, transcript variant X5
tetratricopeptide repeat domain 13, transcript variant X4
tetratricopeptide repeat domain 13, transcript variant X3
tetratricopeptide repeat domain 13, transcript variant X2
tetratricopeptide repeat domain 13, transcript variant X1
tetratricopeptide repeat protein 13 isoform X7
tetratricopeptide repeat protein 13 isoform X6
tetratricopeptide repeat protein 13 isoform X5
tetratricopeptide repeat protein 13 isoform X4
tetratricopeptide repeat protein 13 isoform X3
tetratricopeptide repeat protein 13 isoform X2
tetratricopeptide repeat protein 13 isoform X1
ARV1 homolog, fatty acid homeostasis modulator, transcript variant X1
ARV1 homolog, fatty acid homeostasis modulator, transcript variant X2
family with sequence similarity 89 member A
tripartite motif containing 67, transcript variant X1
tripartite motif containing 67, transcript variant X2
tripartite motif containing 67, transcript variant X3
tripartite motif-containing protein 67 isoform X1
tripartite motif-containing protein 67 isoform X2
tripartite motif-containing protein 67 isoform X3
uncharacterized protein C1orf131 homolog
glyceronephosphate O-acyltransferase, transcript variant X1
dihydroxyacetone phosphate acyltransferase isoform X1
glyceronephosphate O-acyltransferase, transcript variant X2
dihydroxyacetone phosphate acyltransferase isoform X2
egl-9 family hypoxia inducible factor 1, transcript variant X2
egl-9 family hypoxia inducible factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
translin associated factor X, transcript variant X1
translin associated factor X, transcript variant X2
translin-associated protein X isoform X1
translin-associated protein X isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
signal induced proliferation associated 1 like 2, transcript variant X3
signal induced proliferation associated 1 like 2, transcript variant X2
signal induced proliferation associated 1 like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
signal induced proliferation associated 1 like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
signal-induced proliferation-associated 1-like protein 2 isoform X3
signal-induced proliferation-associated 1-like protein 2 isoform X2
signal-induced proliferation-associated 1-like protein 2 isoform X1
signal-induced proliferation-associated 1-like protein 2 isoform X4
nucleoside-triphosphatase, cancer-related, transcript variant X2
cancer-related nucleoside-triphosphatase isoform X2
nucleoside-triphosphatase, cancer-related, transcript variant X1
cancer-related nucleoside-triphosphatase isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3
mitogen-activated protein kinase kinase kinase 21, transcript variant X1
mitogen-activated protein kinase kinase kinase 21, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 21 isoform X1
mitogen-activated protein kinase kinase kinase 21 isoform X2
potassium two pore domain channel subfamily K member 1, transcript variant X1
potassium two pore domain channel subfamily K member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 35 member F3, transcript variant X1
putative thiamine transporter SLC35F3 isoform X1
solute carrier family 35 member F3, transcript variant X2
putative thiamine transporter SLC35F3 isoform X2
cytochrome c oxidase assembly factor 6 homolog
TAR (HIV-1) RNA binding protein 1, transcript variant X1
probable methyltransferase TARBP1 isoform X1
TAR (HIV-1) RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable methyltransferase TARBP1 isoform X2
interferon regulatory factor 2 binding protein 2, transcript variant X2
interferon regulatory factor 2 binding protein 2, transcript variant X1
interferon regulatory factor 2-binding protein 2 isoform X2
interferon regulatory factor 2-binding protein 2 isoform X1
basic salivary proline-rich protein 3-like
uncharacterized LOC119801866, transcript variant X3
uncharacterized LOC119801866, transcript variant X11
uncharacterized LOC119801866, transcript variant X4
uncharacterized LOC119801866, transcript variant X1
uncharacterized LOC119801866, transcript variant X9
uncharacterized LOC119801866, transcript variant X10
uncharacterized LOC119801866, transcript variant X12
uncharacterized LOC119801866, transcript variant X7
uncharacterized LOC119801866, transcript variant X2
uncharacterized LOC119801866, transcript variant X6
uncharacterized LOC119801866, transcript variant X5
uncharacterized LOC119801866, transcript variant X8
translocase of outer mitochondrial membrane 20
mitochondrial import receptor subunit TOM20 homolog
COORDINATES: nucleotide motif:Rfam:12.0:RF00397
par-3 family cell polarity regulator, transcript variant X8
par-3 family cell polarity regulator, transcript variant X3
par-3 family cell polarity regulator, transcript variant X2
par-3 family cell polarity regulator, transcript variant X6
par-3 family cell polarity regulator, transcript variant X14
par-3 family cell polarity regulator, transcript variant X1
par-3 family cell polarity regulator, transcript variant X15
par-3 family cell polarity regulator, transcript variant X5
par-3 family cell polarity regulator, transcript variant X7
par-3 family cell polarity regulator, transcript variant X4
par-3 family cell polarity regulator, transcript variant X10
par-3 family cell polarity regulator, transcript variant X12
par-3 family cell polarity regulator, transcript variant X11
par-3 family cell polarity regulator, transcript variant X13
partitioning defective 3 homolog isoform X1
partitioning defective 3 homolog isoform X3
partitioning defective 3 homolog isoform X2
partitioning defective 3 homolog isoform X6
partitioning defective 3 homolog isoform X4
partitioning defective 3 homolog isoform X5
partitioning defective 3 homolog isoform X7
partitioning defective 3 homolog isoform X8
partitioning defective 3 homolog isoform X15
partitioning defective 3 homolog isoform X14
partitioning defective 3 homolog isoform X10
partitioning defective 3 homolog isoform X11
partitioning defective 3 homolog isoform X12
partitioning defective 3 homolog isoform X13
par-3 family cell polarity regulator, transcript variant X9
partitioning defective 3 homolog isoform X9
uncharacterized LOC119802079, transcript variant X1
uncharacterized LOC119802079, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
coiled-coil domain-containing protein 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments